SEC23A and craniolenticulosutural dysplasia: The key aspect of tissue-specific manifestations can be attributed to reduced SEC23A activity in CLSD-affected patients, which can be sufficient for some cells but inadequate for others, particularly those with a high rate of secretory exocytic pathway activity.